# Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

> **NCT05967143** · — · RECRUITING · sponsor: **Sirtex Medical** · enrollment: 845 (estimated)

## Conditions studied

- Unresectable Hepatocellular Carcinoma (HCC)
- Liver Metastases From Colorectal Cancer (mCRC)

## Interventions

- **DEVICE:** SIRT

## Key facts

- **NCT ID:** NCT05967143
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-19
- **Primary completion:** 2028-06
- **Final completion:** 2029-06
- **Target enrollment:** 845 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05967143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05967143, "Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05967143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*